Not very encouraging based on the sales estimates and dates when they hit peak. EU and China should be worth 2 billion in sales. Sometimes the pump pieces do more harm than good.

Marjac, I would think Denner’s new investment in Amarin will provide us with another source to fund our ongoing shareholder litigation.

Too bad it did not reach stat significance and the only category where the placebo was better was on average days in the hospital. The IPE arm had a lower hospitalization rate, ventilator rate and death rate. Glad I take Vascepa.

I believe Rose was highlighting the employee plan where you can use the coupon.

True but even with the difference in Tier with the coupon 90 days of Vascepa is $9 and 90 days of the generic is $30.

Next time you see your doctor ask how they spend their day and you might be surprised how little time they have. It is the reason why so many stick to existing protocols. Its also shocking how many GPs would not recommend their field. You want to blame someone start first with the University that charge an incredible amount for tuition and yet pay University Presidents millions. Next up, the insurance industry in two parts, first is malpractice and then the healthcare companies. These doctors spend countless hours on administrative tasks to satisfy each insurance company. They then need to see as many patients to cover their costs before making any money.

It might be a case of why bother, it’s a shrinking market and I would think not worth the investment in supply for so few scripts. If Amarin does not go all out in TV, print advertising and invest in a much larger sales force I don’t see much if any increase in scripts. Doctors in the US have so little time to stay up to date they need patients to ask or drug reps to educate them on the meds. I was the one who gave my doctor all the information and he agreed to write the script.

Sounds like he needs to fight it out with GEHA since it sounds like some of the reduce-it criteria is met. I don’t know if they have a complaint bureau in the state your friend resides but if there is one filing a complaint against GEHA might help and a try with the BBB might be worth it. A written explanation from the insurance company to an agency might be if use in any appeal. A complaint to HR on coverage might help as well.

I did not see anything indicating prior authorization, it is listed under the Cardiovascular drug category. I know Aetna requires approval then no issues afterwards.

Has he tried telling GEHA that the generic is not equivalent for the CVD indication? That V being an outcome study drug cannot be compared to a generic that uses different fillers which may not produce the same benefit. If that doesn’t work your friend can refer them to the Delaware lawsuit and plans to inform Amarin GEHA is violating the reduce-it patent. Of course it’s just easier to switch….. I thought that GEHA plan stinks. He could look at Aetna, they cover V with a Dr authorization.

FYI on insurance coverage, just received the 2022 Fed BCBS basic formulary and Vascepa is tier II. Of course the generics are tier 1 but with the coupon a 90 day supply of Vascepa is $9 and the generic is $30. Why would any want the swill at $30 over the brand?

Rose, I know it is a real pain but a letter to the BBB and your state AG might put this into check. Businesses do not want this type of scrutiny and they have to respond to complaints filed to both agencies. I am ready to do the same in Maryland if they try the switch. This is something I suggest everyone try if your script for the CVD indication is changed. The pharmacy and or insurance company must respond to the BBB and AG and in some cases are fined for lack of a reply.

As people encounter these issues the only way to stop it is to file complaints against either the pharmacy if it’s their software or the insurance company. File simultaneous complaints with your state AG office and the better business bureau. It does work as these companies have to respond to the AG and BBB.

Yet they use imaging for the recent approval of an Alzheimer’s drug. I bet if this was Pfizer they would push the use of the image with the FDA. I also don’t see why they can’t use their 1A win to discuss plaque reduction with doctors. This team is too conservative to grow a business.

Thanks Capt and you always post great stuff. It is so confusing they have not tried to get these added to the label. I am still confused about evaporate and the lack of follow up to add that indication to the label.

There is no expense, we just need to submit a proposal by a certain date by someone who owns a certain amount of shares. At least that is what I recall. I just need to find the bylaws again and read through the rules.

Lizzy, it might be time for us to submit the shareholder proposal to hire an independent firm to explore strategic alternatives including the sale of the company. I will try to get some research done on that next week.

You can apply insurance and the coupon, it is the cash price quoted.

Wow, feels like I bought the wrong company. We should put HLS in charge of US sales.

I still see $59.90 for 1 g vs $78 for the generic and I believe the price is without the coupon. Maybe my price is lower because I am a prime member.

Anyone check Vascepa on Amazon lately, price for 30 1 gram capsules is $59 versus generic which is $78. Unreal how they can’t get sales to grow and they should be marketing to prime customers.

This just looks like a coordinated effort to drive it down. Out of the blue we had lawsuits on Friday, followed by a inaccurate hit piece on Monday all during a quiet period before earnings. Where is SEC market monitoring? These walk street blood suckers are not smart, they just manipulate stocks in an organized manner either up or down. How this is not a crime is beyond me. We have been through this before and the stock will snap back to 5 with no news. Then these jackals start over with selling call and put options at 5. All garbage and goes with owning a small company with lots of shares in the hands of retail investors. It’s easy to steal our shares. If they announce a US deal like HLS for the US market it will chase the jackals away.

Also coordinated with fiercepharma and this reeks of stock manipulation. I believe the same thing happened with lawsuits filed and a hit piece once the FDA asked for an Adcom for the reduce-it indication. Your tax dollars hard at work as evidenced by the oversight of the SEC…..pitiful. These wall street manipulators make the mafia look like boy scouts.

This is another hit piece that should result in a review by the SEC if the agency actually did their job and gave a damn. The way they aligned the paragraphs make you think the failed Omega 3s were equivalent to V when we know they are not. Some lawyer from Amarin should send them a warning.

I guess I will pray for Marjac Magic……papa wants a new BMW lol.

They suck and we just have to hold out hope and prayer for Marjac Magic.

I would support a lawsuit if the end result terminated the incentive stock plan. Management, JT, Kennedy and anyone else that supported filing the original suit in the 9th circuit should have been fired immediately for not filing rule 60 on the cropped table. All those shares earned and sold all this time should be refunded to shareholders and the remaining shares cancelled. Give remaining employees cash bonuses for performance.

You are absolutely correct for all leases and I have less than a year left but my car is worth slightly more than my buyout plus the remaining lease payments. If your lease is up, buy your car. If you are buying a car now and they are offering those zero to .9 loans take it. Interest rates are going to accelerate after the first of the year. Printing all this money has consequences that these politicians just don’t understand.

They should just do direct fulfillment, have Amazon stock it, pay a delivery fee to Amazon and cut out the wholesaler and retailer. If you have to , offer a discount for buying Vascepa direct.

I know, I meant to say a ruling from oral arguments on the 14th. I would think we would have a ruling within a few weeks.

If they ask for an extension the answer is F/U…….lol.

Generic aside, that is the market potential when you compare population size. Even if the generics get a chunk of sales we are still talking billions. The ruling on the 14th will tell us if we are out of luck in the US or brighter days are ahead.

Shocking at how bad Amarin has underperformed in the US. Here HLS guides peak of $300 million on a population of 37 million and the US is almost 10x Canada. If HLS was in charge of US peak could be $3 billion.

Any idea when that is scheduled to take place? I thought China made the claim they had a faster path to approval and right now they are just as long as the FDA. It would be great to have another royalty agreement signed real soon.

Anyone have access to script data in Canada? It would be great to see if Pfizer is making any headway.

I am more concerned that we get screwed again by the courts and if that’s the case, the US market is gone. On the bright side, if the judge follows the magistrate and our lawyers bring their A game we might be in for a nice bump up in share price once the judge rules. If we go to trial, I don’t see Hikma taking this gamble nor Healthnet given the large downside.

I am now on year 10 for 2 stents and my cardiologist never gave a date for how long they will hold up. They have said that I have probably experienced regression using statins, Vascepa, exercise and a few lifestyle changes. They stopped my every 2 year nuclear stress testing 4 years ago. When I say they, my first cardiologist left the practice to take over clinical trials and teach at Duke and oddly enough, my current doctor works 1 day a week. He is the head of cardiology devices at the FDA.

Wasn’t the study also done in Iran and it seems such a small set of treated vs. non treated. I doubt this gets much traction.

This has been going on for awhile, someone is making a fortune writing options contracts and it seems they push us to 5 and then it jumps close to 5.50 then back to 5.

Jasbg, , my thoughts and prayers are with you and your wife.

You might want to talk to your doctor about using this drug from Pfizer:

https://www.washingtonpost.com/business/economy/pfizer-had-clues-its-blockbuster-drug-could-prevent-alzheimers-why-didnt-it-tell-the-world/2019/06/04/9092e08a-7a61-11e9-8bb7-0fc796cf2ec0_story.html?outputType=amp